91-08-7

应用筛选条件

关键词:'91-08-7'

显示 1-4 共 4 条结果关于 "91-08-7" 范围论文

[Spectrophotometric determination of aromatic amino compounds with J-acid].

Xiao-hang Yin et al.

Guang pu xue yu guang pu fen xi = Guang pu, 35(1), 193-197 (2015-05-23)

The problems such as chromogenic reaction selectivity, reaction rate, sensitivity and water-solubility of azo compounds were considered. The molecular structures of coupling components were theoretically designed and screened in the present research The reaction conditions and methods of chromogenic reaction

Detection of organ-confined prostate cancer is increased through prostate-specific antigen-based screening.

W J Catalona et al.

JAMA, 270(8), 948-954 (1993-08-25)

To determine whether prostate-specific antigen (PSA)-based screening alters the proportion of organ-confined prostate cancers detected. A prospective, nonrandomized, serial PSA-based screening trial (follow-up from 6 to 37 months), and a concurrent comparison group. General community outpatient screening program based at

Activity and safety of the multi-target tyrosine kinase inhibitor cabozantinib in patients with metastatic gastrointestinal stromal tumour after treatment with imatinib and sunitinib: European Organisation for Research and Treatment of Cancer phase II trial 1317 'CaboGIST'.

Patrick Schöffski et al.

European journal of cancer (Oxford, England : 1990), 134, 62-74 (2020-05-30)

Gastrointestinal stromal tumour (GIST) is commonly treated with tyrosine kinase inhibitors (TKIs), but most patients ultimately develop secondary resistance. Cabozantinib, a multi-targeted TKI inhibitor, has activity in patient-derived GIST mouse xenograft models and can overcome compensatory MET signalling occurring on

Treatment reduction for children and young adults with low-risk acute lymphoblastic leukaemia defined by minimal residual disease (UKALL 2003): a randomised controlled trial.

Ajay Vora et al.

The Lancet. Oncology, 14(3), 199-209 (2013-02-12)

Minimal residual disease (MRD) is the most sensitive and specific predictor of relapse risk in children with acute lymphoblastic leukaemia (ALL) during remission. We assessed whether treatment intensity could be adjusted for children and young adults according to MRD risk

1/1